leadf
logo-loader
viewSilo Pharma Inc

Silo Pharma presents at Proactive's One2One virtual investor forum

Silo Pharma, Inc (OTCQB:SILO) CEO, Eric Weisblum presents at Proactive's One2One virtual investor forum.

Silo Pharma is bridging the gap between traditional pharmaceuticals and the emerging psychedelics space. The developmental-stage biopharmaceutical company’s mission is to identify assets to license and fund the research which it believes could transform both the well-being of patients and the healthcare system at large.

 

Quick facts: Silo Pharma Inc

Price: 0.285 USD

OTCQB:SILO
Market: OTCQB
Market Cap: $24.28 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Silo Pharma Inc named herein, including the promotion by the Company of Silo Pharma Inc in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Proactive One2One Forum, Tuesday 02/23 13:00 EST

We are delighted to invite you to attend the next Proactive ONE2ONE Investor Forum which is taking place on Tuesday February 23rd from 1pm EST via our online interactive webinar conference Proactive continues to bring you the best investment opportunities safely to the comfort of your own...

1 week, 5 days ago

2 min read